Novo Nordisk rebrands diabetes tablet as Ozempic in US
Go back to Novo Nordisk rebrands diabetes tablet as Ozempic in US| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1098.57 -13.43 (1.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1112.00 | 52 Week High | $88.16 | |||
| Open | $1120.49 | 52 Week Low | $67.88 | |||
| Day High | $1122.33 | P/E | 254.30 | |||
| Day Low | $1088.66 | EPS | $4.32 | |||
| Volume | 4,470,563 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 43.19 -0.33 (0.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.52 | 52 Week High | $59.00 | |||
| Open | $43.45 | 52 Week Low | $32.80 | |||
| Day High | $44.00 | P/E | N/A | |||
| Day Low | $42.52 | EPS | $0.00 | |||
| Volume | 8,996,733 | |||||
